Sorry you asked? , and the battles over patent-eligibility.

Genetic testing for inherited cancer risk changed dramatically when the US Supreme Court handed down unanimous rulings in (2012) and (2013). Those decisions struck down claims to methods based on 'laws of nature' () and DNA molecules corresponding to sequences found in nature (). Senators Thom Tillis (R-NC) and Christopher Coons (D-DE) introduced legislation that would abrogate those decisions and specify narrow statutory exclusions to patent-eligibility in §101 of the US Patent Act.